Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05119153 · ClinicalTrials.gov registry record · NA
Effects of Coffee Roasting on Blood Sugar Levels in Healthy Humans
A NA study, sponsored by North Carolina State University.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT05119153: Completed NA study, sponsored by North Carolina State University.
NCT05119153 is a NA study that has completed, run by North Carolina State University. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05119153, a NA study, has completed, sponsored by North Carolina State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The present study determined the effects light, medium, and dark roasted, brewed coffees on blood glucose responses in normal (n = 19) subjects.
Primary Outcome
Each week, fasted baseline and postprandial measurements taken out to 240 minutes
Interventions
- DIETARY_SUPPLEMENT Placebo Comparator
- DIETARY_SUPPLEMENT Light Roasted Coffee
- DIETARY_SUPPLEMENT Medium Roasted Coffee
- DIETARY_SUPPLEMENT Dark Roasted Coffee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2019-11-05 |
| Est. Completion | 2021-10-31 |
| Phase | NA |
What the finished NCT05119153 record still lists
NCT05119153 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which Placebo Comparator is the first listed.
NCT05119153 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05119153 about?
NCT05119153 is a clinical study titled "Effects of Coffee Roasting on Blood Sugar Levels in Healthy Humans". The present study determined the effects light, medium, and dark roasted, brewed coffees on blood glucose responses in normal (n = 19) subjects.
What is the current status of trial NCT05119153?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2019-11-05. Estimated completion is 2021-10-31.
What interventions are being tested in trial NCT05119153?
The interventions under investigation include: Placebo Comparator (DIETARY_SUPPLEMENT), Light Roasted Coffee (DIETARY_SUPPLEMENT), Medium Roasted Coffee (DIETARY_SUPPLEMENT), Dark Roasted Coffee (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05119153?
This trial is sponsored by North Carolina State University, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05119153's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI